Literature DB >> 6756787

Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.

H D Isenberg, J Sampson-Scherer, R Cleeland, E Titsworth, G Beskid, J G Christenson, W F DeLorenzo, J Unowsky.   

Abstract

Recent clinical isolates (approximately 150 strains) of the family Enterobacteriaceae were examined by agar diffusion, microdilution, and the Autobac automated system for their responses to beta-lactam antibiotics singly and in combination with amdinocillin (formerly called mecillinam). The ratio of ampicillin, carbenicillin, and cephalothin to amdinocillin was maintained at a 10:1 ratio in most of the evaluations. The same isolates were studied in mice challenged with 100 to 1000 LD50s and treated with graded doses of the antibiotics singly and in combination. Efficacy in vivo was based on the concentration of antibiotic in milligrams per kilograms (mg/kg) required to protect 50% of the animals (PD50). After a single administration of the antibiotics, plasma levels were determined in the critical time period (30 min to 4 hr) during which the acute, overwhelming systemic infections could be controlled by appropriate therapy. Regression curves comparing in vivo and in vitro results were used to establish cut-off points for categorizing bacterial susceptibility in each of the laboratory tests for the single agents and combinations. A high degree of synergism between amdinocillin and the beta-lactam agents was demonstrated in animals (54 to 78% of the strains examined) and to a lesser extent by laboratory methodologies. There was an excellent correlation of in vivo and in vitro responses to ampicillin, carbenicillin, and cephalothin alone and in combination with amdinocillin for those species for which the single antibiotics are generally indicated. The correlations validated the chosen cut-off points. The correlation of in vivo and in vitro responses to the single or combined antibiotics was generally poorer for those species not usually responsive to the single antibiotics. The greatest difficulty in predicting proper in vivo responses, based on the results of in vitro tests, was observed with amdinocillin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756787     DOI: 10.3109/10408418209113505

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  6 in total

1.  Critical evaluation of amdinocillin disk susceptibility tests correlated with agar dilution tests.

Authors:  A L Barry
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

2.  Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillin.

Authors:  C C Sanders; W E Sanders; R V Goering; R V McCloskey
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

3.  Clinical laboratory studies of disinfection with Sporicidin.

Authors:  H D Isenberg
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

4.  Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse model.

Authors:  M B Kerrn; N Frimodt-Møller; F Espersen
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

5.  Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.

Authors:  H D Isenberg; R C Tilton; A L Barry; G Beskid; R Cleeland; V Fallat; P R Murray; C Pierson; E Squires
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

6.  Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants.

Authors:  David M Livermore; Marina Warner; Shazad Mushtaq; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.